Using genome-wide approaches, we and others demonstrated there were very little overlaps of ERα targeted genes in breast cancer cells versus acquired endocrine-resistant breast cancer cells indicating distinct transcriptional regulatory mechanisms underlying endocrine resistance33–37. This evidence concerns the gene ESR1 and breast carcinoma.